NAMPT is crucial for replenishment of the intracellular NAD pool, and in several cancer types - including prostate, gastric, breast, and ovarian cancer, gliomas, leukemia, lymphoma, and myeloma - NAMPT was found to be overexpressed [10] and associated with disease progression [11]. This evidence concerns the gene NAMPT and ovarian cancer.